Extracorporeal Membrane Oxygenation Complication Clinical Trial
Official title:
Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement
The primary objective of this work is to study the 1-year prognosis of patients who received Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock with the need for blood transfusion. Secondary objectives are to determine whether the transfusion strategy used (liberal or restrictive) still has an impact on overall mortality. We will also determine the factors associated with overall in-hospital mortality and look at the impact of transfusion in relation to the risk of hemolysis on the consequences in the occurrence of long-term chronic renal failure.
The study of the prognostic impact of blood transfusion at 1 year in patients assisted by Veno-arterial extracorporeal membrane oxygenation in the context of cardiogenic shock would provide objective answers and optimize the decision to set up this assistance with regard to the possible long-term consequences. This decision currently remains at the discretion of the expert teams managing these patients. The inclusion of patients in a state of cardiogenic shock under Veno-arterial extracorporeal membrane oxygenation with the need for transfusion, will therefore allow the elaboration of a multicentric observational study interested in the prognosis at 1 year of patients under VA ECMO according to the adopted transfusion threshold. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05486559 -
The ECMO-Free Trial
|
N/A | |
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Not yet recruiting |
NCT05306392 -
Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation
|
N/A | |
| Terminated |
NCT02280460 -
ECMO: Optimization of Its Use
|
||
| Completed |
NCT02271126 -
TEG Anticoagulation Monitoring During ECMO
|
Phase 1 | |
| Recruiting |
NCT05444764 -
PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
|
||
| Completed |
NCT03659513 -
The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
|
||
| Not yet recruiting |
NCT06338345 -
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
|
N/A | |
| Completed |
NCT05948332 -
Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
|
||
| Recruiting |
NCT04273607 -
Anticoagulation-free VV ECMO for Acute Respiratory Failure
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04956497 -
Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China
|
||
| Completed |
NCT04052230 -
Evolution of Diaphragm Thickness Under Veno-arterial ECMO
|
||
| Completed |
NCT04620005 -
Impact of Extra Corporal Membrane Oxygenation Services on Burnout Development in Intensive Care Units.
|
||
| Terminated |
NCT04524585 -
Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome
|
N/A | |
| Recruiting |
NCT05721105 -
Evaluation of Long-term Quality of Life in Children Supported With ExtraCorporeal Membrane Oxygenation (ECMO)
|
||
| Recruiting |
NCT06095518 -
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
|
||
| Recruiting |
NCT03965208 -
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
|
Phase 4 | |
| Not yet recruiting |
NCT05814094 -
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
|
N/A | |
| Not yet recruiting |
NCT06319677 -
PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment
|
||
| Completed |
NCT05338593 -
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
|